Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/10/1990 | CA2000821A1 Inhibitors of platelet binding |
05/10/1990 | CA2000483A1 Antibody-drug conjugates |
05/09/1990 | EP0367713A1 Antidote for blood anticoagulants based on factor VIII |
05/09/1990 | EP0367666A1 Specific nucleic-acid fragments of the human villin gene and their application to diagnostic ends |
05/09/1990 | EP0367644A1 Nucleotide sequence codings for a protein with urea reactivity |
05/09/1990 | EP0367641A2 Lymphokines, DNA sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines |
05/09/1990 | EP0367575A1 Human lymphotoxin |
05/09/1990 | EP0367566A1 Interleukin-4 receptors |
05/09/1990 | EP0367554A2 Insulin binders and inhibitors of insulin binding |
05/09/1990 | EP0367514A2 Human leukocyte elastase inhibitors and methods for producing and using same |
05/09/1990 | EP0367489A2 Thromboresistant materials and methods for making same |
05/09/1990 | EP0367475A2 Process for producing haemoglobin concentrate |
05/09/1990 | EP0367474A1 Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
05/09/1990 | EP0367463A1 Calcitonin gene related peptide analogues |
05/09/1990 | EP0367447A1 Human epithelial transforming growth factor |
05/09/1990 | EP0367302A2 Process for semi-synthesis of human insulin, water-soluble cross-linked Achromobacter protease I for use therein and a process for preparing the same |
05/09/1990 | EP0367220A2 Albumin preparation and process for preparing the same |
05/09/1990 | EP0367166A1 Modified interleukin-2 and production thereof |
05/09/1990 | EP0367163A2 Process for producing an insulin precursor in streptomyces |
05/09/1990 | EP0367161A2 Process for selectively hydrolising fusion proteins |
05/09/1990 | EP0367063A1 Isolation and cloning of complementary DNA for gene coding of bovine trophoblast protein-1 |
05/09/1990 | EP0366816A1 Recombinant platelet-derived growth factor A-chain derived from endothelial cells |
05/09/1990 | EP0366777A1 Stimulation of chemotaxis by chemotactic peptides. |
05/09/1990 | EP0366728A1 Polypeptides with fibronectin activity. |
05/09/1990 | EP0366689A1 A method for sample extraction, purification, concentration and quantification of low molecular weight organic compounds and an analytical kit for carrying out said method |
05/09/1990 | EP0366669A1 Malic acid derivative containing renin inhibiting peptides |
05/09/1990 | EP0366662A1 Aminopeptidase for removing n-terminal methionine from proteins and proteins prepared therefrom |
05/09/1990 | EP0366661A1 HUMAN t-PA(u-PA) SUBSTITUTION-MUTANT PROTEINS, RECOMBINANT DNA CODING THEREFOR, TRANSFECTED HOST CELLS, PREPARATION OF THE MUTANT PROTEINS, AND PHARMACEUTICAL COMPOSITIONS |
05/09/1990 | CN1041951A Novel peptidase inhibitors |
05/09/1990 | CN1041950A Peptidase inhibitors |
05/08/1990 | US4923967 Interleukins, sulfitolysis |
05/08/1990 | US4923964 Immunomodulators, thymus and spleen disorders, lymphocytes |
05/08/1990 | US4923815 Process for heat treating thrombin |
05/08/1990 | US4923808 Fusion transforming host cells |
05/08/1990 | US4923807 Arg-Serpin human plasminogen activator inhibitor designated PAI-2 |
05/08/1990 | US4923805 Culturing cells capable of glycosylating proteins; gene expression dimerization |
05/08/1990 | US4923799 T cell specific cDNA clone |
05/08/1990 | US4923696 Method to prepare a neurotrophic composition |
05/08/1990 | CA1268900A1 Immunomodulators obtained by hemisynthesis of a bacterial polysaccharide isolated from a mutant strain of klebsiella pneumoniae |
05/08/1990 | CA1268899A1 Cyclic hexapeptide somatostatin analogs |
05/08/1990 | CA1268898A1 Growth hormone-releasing peptides and method of treating mammals therewith |
05/08/1990 | CA1268897A1 Gonadoliberin derivatives and process for the preparation thereof |
05/08/1990 | CA1268722A1 Preparation process of a strain, specifically of yeast, transformed by an expression vector, which can be cultured on a complete culture medium without selection pressure and strain obtained by said process |
05/08/1990 | CA1268721A1 Hydrid promoters let and lec |
05/08/1990 | CA1268707A1 Process for the virus-inactivation of immunoglobulin |
05/07/1990 | CA2002352A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
05/07/1990 | CA2002261A1 High molecular weight human angiogenic factors |
05/03/1990 | WO1990004790A1 Method for detection of human papillomavirus (hpv) for diagnostic purposes |
05/03/1990 | WO1990004788A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
05/03/1990 | WO1990004650A1 A purification process for covalently bound dna/protein complexes |
05/03/1990 | WO1990004642A1 Method for isolating glycosylated interleukine-2 and glycosylated interleukine-2 |
05/03/1990 | WO1990004641A1 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS) |
05/03/1990 | WO1990004640A1 cDNAs CODING FOR THE η SUBUNIT OF THE HIGH-AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
05/03/1990 | WO1990004637A1 NUCLEOTIDE SEQUENCES EXPRESSING THE ADENYL CYCLASE OF $i(B. ANTHRACIS) |
05/03/1990 | WO1990004635A1 Thrombolytic agents with modified kringle domains |
05/03/1990 | WO1990004632A1 Transgenic animals for testing multidrug resistance |
05/03/1990 | WO1990004606A1 A process for fractionating polyethylene glycol (peg)-protein adducts and an adduct of peg and granulocyte-macrophage colony stimulating factor |
05/03/1990 | WO1990004605A1 Calcitonin gene related peptide analogues |
05/03/1990 | WO1990004604A1 Yeast heat shock protein 60 and analogs |
05/03/1990 | WO1990004414A1 Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection |
05/03/1990 | WO1990004413A1 ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED Fc REGIONS |
05/03/1990 | WO1990004411A1 Immunogenically active fractions of borrelia burgdorferi |
05/03/1990 | WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment |
05/03/1990 | WO1990004409A1 Human leukocyte elastase inhibitors and methods of producing and using same |
05/03/1990 | WO1990004408A1 Composition and treatment with biologically active peptides and certain anions |
05/03/1990 | WO1990004407A1 Cpf peptide compositions and uses |
05/03/1990 | WO1990004406A1 Drug containing a glycosylated interleukine-2 |
05/03/1990 | WO1990003181A3 Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product |
05/03/1990 | WO1990001549A3 Gene encoding protein antigens of plasmodium falciparum |
05/03/1990 | WO1990000594A3 Recombinant mycobacterial expression vehicles and uses therefor |
05/03/1990 | CA2002062A1 Process for the preparation of an insulin precursor in streptomycetes |
05/02/1990 | EP0366612A2 Purification of green-plant phytochrome protein and cloning of green-phytochrome genes |
05/02/1990 | EP0366550A1 Nucleotide sequences expressing adenylate cyclase from B.anthracis, proteins having the activity of this adenylate cyclase and biological uses |
05/02/1990 | EP0366549A1 Derivatives of adenyl cyclase and biological use thereof |
05/02/1990 | EP0366532A1 Medical preparations containing glycosylated interleukin-2 |
05/02/1990 | EP0366438A1 Method for the separation of nucleic acids from protein material based on cation exchangers |
05/02/1990 | EP0366400A2 DNA encoding human serum albumin a (HSA), plasmids and hosts containing such DNA, and the production of HSA |
05/02/1990 | EP0366397A1 Novel bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
05/02/1990 | EP0366239A1 Purification process for recombinant influenza proteins |
05/02/1990 | EP0366238A2 Influenza vaccinal polypeptides |
05/02/1990 | EP0366091A2 Muteins of a tissue plasminogen activator with duplicated domains |
05/02/1990 | EP0366043A1 Monoclonal antibody |
05/02/1990 | EP0366016A2 Endothelin DNA and use thereof |
05/02/1990 | EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment |
05/02/1990 | EP0365858A2 Process for reducing the aggregate content of growth hormone-like materials |
05/02/1990 | EP0365837A2 Intercellular adhesion molecules, and their binding ligands |
05/02/1990 | EP0365779A2 Cyclic GRF-analogs II |
05/02/1990 | EP0365657A1 Dna encoding androgen receptor protein |
05/02/1990 | EP0365654A1 Elastomeric polypeptides as vascular prosthetic materials. |
05/02/1990 | EP0365643A1 Compounds for diagnosis and/or therapy of tumours |
05/02/1990 | EP0365568A1 Proteins and derivatives thereof |
05/02/1990 | EP0197149B1 Method of obtaining human leukocytic interferon |
05/02/1990 | CN1007780B Immonologically active whey fraction and recovery process |
05/01/1990 | US4922015 Synthesis of peptide amides by means of a solid phase method using acid-labile anchoring groups |
05/01/1990 | US4921841 Immunoaffinity purification of phytolaccin proteins and their use in treating Herpes Simplex virus type II |
05/01/1990 | US4921802 Plant virus cDNA |
05/01/1990 | US4921790 Tumor specific assay for CA125 ovarian cancer antigen |
05/01/1990 | US4921699 Polypeptides having interferon activity |
05/01/1990 | US4921698 Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4 |
05/01/1990 | CA2000887A1 Thromboresistant materials and methods for making same |